Cantor Fitzgerald Starts VolitionRX (VNRX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
VolitionRx Limited to Present at Conferences in March 2021
March 8, 2021 4:15 PM ESTAUSTIN, Texas, March 8, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, Cameron Reynolds, and its Executive Vice President, Investor Relations, Scott Powell, are scheduled to present at six conferences in March 2021.
During the conferences, Mr. Reynolds and Dr. Powell will outline Volition's business, clinical, regulatory and operational milestones.
Details of the conference presentations (all virtual) are as follows:
H.C. Wainwright Global Life Sciences Conference - March 9-10, 2021Presentation: Tuesday March 9 at 7:00 am ETRegister:... More
